ACLEXA

Brand name authorized in: Estonia Lithuania Poland

Active ingredients

The drug ACLEXA contains one active pharmaceutical ingredient (API):

1 Celecoxib
UNII JCX84Q7J1L - CELECOXIB

Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.

Read about Celecoxib

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Celecoxib
M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
EE
Ravimiamet
Identifier(s): 1596696, 1596708, 1596719, 1596720, 1596731, 1596742, 1596753, 1596764, 1596775, 1596786, 1596797, 1596809, 1596810, 1596821, 1596832, 1596843, 1815421, 1815432, 1815443, 1815454, 1815465, 1815476, 1815487, 1815498, 1861343, 1861354, 1861365, 1861376, 1861387, 1861411
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1068247, 1068248, 1072200, 1072201, 1072202, 1072203, 1072204, 1072205, 1072206, 1072207, 1072208, 1072209, 1072210, 1072211, 1072212, 1072213
PL
Rejestru Produktów Leczniczych
Identifier(s): 100316800, 100316817